MeSH term
Frequency | Condition_Probility | Chromosome Mapping | 3 | 0.0 |
*Chromosomes, Human, Pair 5 | 2 | 0.0 |
Crohn Disease/*genetics | 9 | 24.0 |
Cytokines/*genetics | 2 | 1.0 |
*Genetic Predisposition to Disease | 4 | 0.0 |
Humans | 14 | 0.0 |
Linkage Disequilibrium | 2 | 0.0 |
Polymorphism, Single Nucleotide | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 11 | 0.0 |
*Variation (Genetics) | 2 | 0.0 |
Colitis, Ulcerative/genetics | 2 | 11.0 |
Inflammatory Bowel Diseases/*genetics | 2 | 8.0 |
*Linkage (Genetics) | 2 | 0.0 |
Chromosomes, Human, Pair 5/*genetics | 8 | 9.0 |
Colitis, Ulcerative/ethnology/genetics | 2 | 100.0 |
Crohn Disease/ethnology/genetics | 2 | 100.0 |
Haplotypes | 6 | 0.0 |
Membrane Transport Proteins/genetics | 2 | 6.0 |
Carnitine/metabolism | 2 | 28.0 |
Carrier Proteins/*genetics | 2 | 0.0 |
Genotype | 6 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 3 | 0.0 |
Membrane Proteins/*genetics | 2 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Mutation | 2 | 0.0 |
Phenotype | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
Adolescent | 2 | 0.0 |
Adult | 3 | 0.0 |
Aged | 2 | 0.0 |
Child | 2 | 0.0 |
Female | 5 | 0.0 |
Male | 5 | 0.0 |
Middle Aged | 2 | 0.0 |
Risk Factors | 3 | 0.0 |
Colitis, Ulcerative/*genetics | 2 | 7.0 |
Canada | 2 | 1.0 |
Case-Control Studies | 3 | 0.0 |
Japan | 2 | 0.0 |
